E-Nema GmbH – Trademark Portfolio

Entity Type: 03

E-Nema GmbH holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include DIANEM, NEMYCEL, NEMAPLUS, and NEMAGREEN. The owner is based in Schwentinental.

Klausdorfer Strasse 28-36

Schwentinental 24223 , DE

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NEMATOP
NEMATOP
Cancelled 2017
DIANEM
DIANEM
Registered 2017
NEMASTAR
NEMASTAR
Cancelled 2017
NEMAPOM
NEMAPOM
Cancelled 2017
NEMAFLOR
NEMAFLOR
Cancelled 2017
NEMYCEL
NEMYCEL
Registered 2006
NEMACEL
NEMACEL
Abandoned 2005
NEMAGREEN
NEMAGREEN
Registered 2004
NEMAPLUS
NEMAPLUS
Registered 2004
SALICO
SALICO
Cancelled 2004

Trademark Classifications

E-Nema GmbH's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does E-Nema GmbH have?

E-Nema GmbH has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 5 cancelled.

What trademark classes does E-Nema GmbH file in?

E-Nema GmbH files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are E-Nema GmbH's most well-known trademarks?

E-Nema GmbH's registered trademark portfolio includes well-known marks such as DIANEM, NEMYCEL, NEMAPLUS, and NEMAGREEN. These are among 4 currently registered trademarks in the portfolio.

What is E-Nema GmbH's trademark registration success rate?

E-Nema GmbH has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.